Court may expand 340B drug discount program as CMS preps $9B for 1,700 hospitals
A South Carolina federal court on Friday endorsed the idea that the Health Resources and Services Administration’s definition of “patient” under its 340B program for the poorest patients is not broad enough, potentially opening the door for hospitals and other covered entities to further expand the ballooning drug discount program.
The court explained its own broader definition by noting that Congress chose to enact the 340B statute without any limitation on patient eligibility and, in fact, omitted language requiring the individual to receive the drug or biological “as a patient of the covered entity.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.